Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) EPS (Basic) (2021 - 2025)

Bioventus (BVS) has disclosed EPS (Basic) for 5 consecutive years, with $0.22 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) changed N/A year-over-year to $0.22, compared with a TTM value of $0.34 through Dec 2025, up 157.63%, and an annual FY2025 reading of $0.34, up 160.71% over the prior year.
  • EPS (Basic) was $0.22 for Q4 2025 at Bioventus, up from $0.05 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.22 in Q4 2025 and bottomed at -$2.24 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$0.29, with a median of -$0.09 recorded in 2023.
  • The sharpest move saw EPS (Basic) crashed 201797.82% in 2022, then soared 145.45% in 2025.
  • Year by year, EPS (Basic) stood at -$0.0 in 2021, then plummeted by 201797.82% to -$1.11 in 2022, then surged by 91.89% to -$0.09 in 2023, then fell by 22.22% to -$0.11 in 2024, then surged by 300.0% to $0.22 in 2025.
  • Business Quant data shows EPS (Basic) for BVS at $0.22 in Q4 2025, $0.05 in Q3 2025, and $0.11 in Q2 2025.